Possibilities of Improving the Clinical Value of Immune Checkpoint Inhibitor Therapies in Cancer Care by Optimizing Patient Selection von Iivanainen, Sanna, Koivunen, Jussi P.

Volltext

Early PD-1 Therapy Discontinuation in Responding Metastatic Cancer Patients von Iivanainen, Sanna, Koivunen, Jussi P.

Volltext

Complications and outcome after free flap surgery for cancer of the head and neck von Lahtinen, S., Koivunen, P., Ala-Kokko, T., Kaarela, O., Ohtonen, P., Laurila, P., Liisanantti, J.H.

Volltext

EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer von KOIVUNEN, Jussi P, MERMEL, Craig, LEE, Jinseon, RICHARDS, William G, SUGARBAKER, David J, DUCKO, Christopher, LINDEMAN, Neal, MARCOUX, J. Paul, ENGELMAN, Jeffrey A, GRAY, Nathanael S, LEE, Charles, MEYERSON, Matthew, ZEJNULLAHU, Kreshnik, JDNNE, Pasi A, MURPHY, Carly, LIFSHITS, Eugene, HOLMES, Alison J, HWAN GEUN CHOI, KIRN, Jhingook, CHIANG, Derek, THOMAS, Roman

Volltext

Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies von Iivanainen, Sanna, Ekstrom, Jussi, Virtanen, Henri, Kataja, Vesa V., Koivunen, Jussi P.

Volltext

Trastuzumab-induced cardiotoxicity and its risk factors in real-world setting of breast cancer patients von Moilanen, Tiina, Jokimäki, Anna, Tenhunen, Olli, Koivunen, Jussi P.

Volltext

Bcl-xl and Mcl-1 are the major determinants of the apoptotic response to dual PI3K and MEK blockage von JOKINEN, ELINA, KOIVUNEN, JUSSI P

Volltext

Alternative dosing of dual PI3K and MEK inhibition in cancer therapy von Jokinen, Elina, Laurila, Niina, Koivunen, Jussi P

Volltext

Tonsillar microbiota in children with PFAPA (periodic fever, aphthous stomatitis, pharyngitis, and adenitis) syndrome von Tejesvi, M. V., Uhari, M., Tapiainen, T., Pirttilä, A. M., Suokas, M., Lantto, U., Koivunen, P., Renko, M.

Volltext

A simple novel prognostic model for early stage oral tongue cancer von Almangush, A, Coletta, R.D, Bello, I.O, Bitu, C, Keski-Säntti, H, Mäkinen, L.K, Kauppila, J.H, Pukkila, M, Hagström, J, Laranne, J, Tommola, S, Soini, Y, Kosma, V.-M, Koivunen, P, Kowalski, L.P, Nieminen, P, Grénman, R, Leivo, I, Salo, T

Volltext

805: Cancer stem cell-like cells mediate adaptive resistance to targeted cancer therapies von Jokinen, E, Laurila, N, Koivunen, P, Koivunen, J.P

Volltext

The prognostic and predictive roles of plasma C‐reactive protein and PD‐L1 in non‐small cell lung cancer von Kuusisalo, Saara, Tikkanen, Antti, Lappi‐Blanco, Elisa, Väisänen, Timo, Knuuttila, Aija, Tiainen, Satu, Ahvonen, Jarkko, Iivanainen, Sanna, Koivunen, Jussi P.

Volltext

Predicting Objective Response Rate (ORR) in Immune Checkpoint Inhibitor (ICI) Therapies with Machine Learning (ML) by Combining Clinical and Patient-Reported Data von Iivanainen, Sanna, Ekström, Jussi, Virtanen, Henri, Kataja, Vesa V., Koivunen, Jussi P.

Volltext

MEK and PI3K inhibition in solid tumors: rationale and evidence to date von Jokinen, E., Koivunen, J.P.

Volltext

Short- and long-term mortality and causes of death after reconstruction of cancers of the head and neck with free flaps von Lahtinen, S., Koivunen, P., Ala-Kokko, T., Kaarela, O., Ohtonen, P., Laurila, P., Liisanantti, J.H.

Volltext

PO-063: Waiting time and fast track model for head and neck cancer patients in Finland von Irjala, H, Halme, E, Makitie, A, Atula, T, Koivunen, P

Volltext

Treatment outcomes of non-small cell lung cancers treated with EGFR tyrosine kinase inhibitors: a real-world cohort study von Manninen, Otto, Puuniemi, Laura, Iivanainen, Sanna, Arffman, Martti, Kaarteenaho, Riitta, Koivunen, Jussi P

Volltext

Association of diagnostic delays to survival in lung cancer: single center experience von Alanen, Virve, Koivunen, Jussi P.

Volltext

Craniomaxillofacial osteosarcoma — The role of surgical margins von Kontio, R., Hagström, J., Lindholm, P., Böhling, T., Sampo, M., Mesimäki, K., Saarilahti, K., Koivunen, P., Mäkitie, A.A.

Volltext

Prognostic and predictive role of tumour-associated macrophages in HER2 positive breast cancer von Honkanen, Tiia J., Tikkanen, Antti, Karihtala, Peeter, Mäkinen, Markus, Väyrynen, Juha P., Koivunen, Jussi P.

Volltext